Sonography and Haemophilia
Self-conducted Sonographic Monitoring of the Target Joints in Patients With Severe Haemophilia
1 other identifier
observational
5
1 country
1
Brief Summary
The aim of this study is to evaluate the possibility of establishing a patient-based ultrasound monitoring of the knee (representing a target joint accessible with any hand) with a handheld device: The following questions will be answered:
- 1.What is necessary for the organisational implementation of a patient-based ultrasound monitoring in patients with haemophilia?
- 2.Is it possible to train patients with haemophilia to perform sonography of their target joints?
- 3.Does a patient-based ultrasound monitoring with a handheld device work in a home setting?
- 4.What is the quality of the patient's self-acquired ultrasound images?
- 5.Will the test persons be able to distinguish normal findings from (any) pathologic findings?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Feb 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 25, 2020
CompletedFirst Posted
Study publicly available on registry
September 16, 2020
CompletedStudy Start
First participant enrolled
February 8, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2022
CompletedMay 19, 2022
May 1, 2022
1.5 years
August 25, 2020
May 18, 2022
Conditions
Outcome Measures
Primary Outcomes (4)
Landmarks of the Hemophilia Early Arthropathy Detection with Ultrasound (HEAD-US) protocol - Anterior mid-sagittal ultrasound image
The patients will perform an ultrasound of their left and right knee according to the HEAD-US protocol. The following ultrasonic image is needed: Anterior mid-sagittal ultrasound image. Patella, distal femur, suprapatellar recess, suprapatellar fat pad and prefemoral fat pad must be visible.
5 min
Landmarks of the Hemophilia Early Arthropathy Detection with Ultrasound (HEAD-US) protocol - Anterolateral transverse ultrasound image
The patients will perform an ultrasound of their left and right knee according to the HEAD-US protocol. The following ultrasonic image is needed: Anterolateral transverse ultrasound image. Patellofemoral joint, lateral parapatellar recess, lateral patellar retinaculum and lateral femoral condyle must be visible.
5 min
Landmarks of the Hemophilia Early Arthropathy Detection with Ultrasound (HEAD-US) protocol - Transverse ultrasound image - Transverse ultrasound image
The patients will perform an ultrasound of their left and right knee according to the HEAD-US protocol. The following ultrasonic image is needed: Transverse ultrasound image. Medial facets of the trochlea, lateral facets of the trochlea and cartilage must be visible.
5min
Landmarks of the Hemophilia Early Arthropathy Detection with Ultrasound (HEAD-US) protocol - Coronal ultrasound image
The patients will perform an ultrasound of their left and right knee according to the HEAD-US protocol. The following ultrasonic image is needed: Coronal ultrasound image. Medial meniscus, boundaries of the femur, boundaries of the tibia must be visible.
5 min
Study Arms (1)
Adult patients with severe haemophilia A or B
* Adult patients (≥ 18 years of age) suffering from severe haemophilia A or B * No professional medical background * Submitted written consent to participate in the study and to use their study related pseudonymised data
Interventions
The aim of this study is to evaluate the possibility of establishing a patient-based ultrasound monitoring of the knee (representing a target joint accessible with any hand) with a handheld device.
Eligibility Criteria
Adult patients (≥ 18 years of age) suffering from severe haemophilia A or B. Haemophilia is an X-linked recessive genetic bleeding disease characterised by absence or deficiency of factor VIII in haemophilia A or factor IX in haemophilia B. This can cause spontaneous bleedings, particularly into joints. Joint bleedings initiate an inflammatory process characterised by chronic synovitis that causes degeneration of the affected joints and results in haemophilic arthropathy
You may qualify if:
- Adult patients (≥ 18 years of age) suffering from severe haemophilia A or B
- No professional medical background
- Submitted written consent to participate in the study and to use their study related pseudonymized data
You may not qualify if:
- Patients suffering from other bleeding diseases
- Participants \< 18 years of age
- Participants without written consent
- Professional medical background
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital, Bonnlead
- Swedish Orphan Biovitrumcollaborator
Study Sites (1)
University Hospital of Bonn
Bonn, Northrhine Westfalia, 53127, Germany
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Andreas Strauß, PD Dr.
Medicine of the University of Bonn
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Specialist in orthopedics and trauma surgery
Study Record Dates
First Submitted
August 25, 2020
First Posted
September 16, 2020
Study Start
February 8, 2021
Primary Completion
July 31, 2022
Study Completion
December 31, 2022
Last Updated
May 19, 2022
Record last verified: 2022-05
Data Sharing
- IPD Sharing
- Will not share
The publication of anonymous patient data is not allowed by informed consent.